As per a report by Markets and Markets, the Clinical Trial Market is projected to reach $1,590 million by 2025 from $801 million in 2020, at a CAGR of 14.7 percent during the forecast period. The growth of the Clinical Trial market is driven by rising industry-academia collaborations, increased number of clinical trials, growing technology adoption, and government support for research trials. The health market in India has seen a significant rise recently, especially with the advent of multiple start-ups and SMEs with interest in diverse areas of medicines including, but not limited to, pharmaceutical drug development and drug delivery systems, medical devices, and complementary or alternative medicine such as Ayurveda or herbal medicines.
The current threat from the COVID-19 pandemic also resulted in substantial input of interest and finance in health market from the Government of India and entrepreneurs. The development of new technologies and inventions in the health domain are also shaping into new products and devices which would require conducting of ethical clinical trials to assess their success and this will provide the clinical trial management system market the correct opportunities to flourish exponentially.
Headquartered in Delhi-NCR, Clinical Research Network India (CRN India), a 'Make In India' contract research organization (CRO) aims to provide a comprehensive solution for executing high quality, ethical clinical research and studies, from start to finish, to facilitate and accelerate development of life-saving drugs and devices. Set up with a vision to provide healthy life to every individual through translational research by facilitating ethical clinical research in the country, CRN India has partnered with several researchers, clinicians, board and GCP certified practicing primary care physicians in diverse core therapeutic areas, contract research organizations, site management organizations, the Government, health associations, not for profit organizations, biopharmaceutical, and medical device companies as well as the patients and public, in order to provide convenient solutions to potential hurdles associated with conducting clinical research in India.
“At CRN India, we offer practical help in identifying and recruiting patients for Portfolio studies, so that researchers can be confident of completing the study on time. We have conducted high quality Phase I – IV clinical trials on vaccines, drugs, biologicals, vaccines, devices in both adult and pediatric population. Other than experienced investigators, we also provide science writers as another value- added service. Some of our major services include investigator selection, research site identification, clinical study approval (including Ethics committee/Institutional review board approval), protocol development (background research, writing study protocols and reports, data analysis etc.) and most importantly a fast, secure ethical conduct of the study ensuring sanctity of the clients’ intellectual property”, shares Dr. Anit Singh, MBBS, MD (AIIMS), CEO, CRN India.
Taking Unique Approach To Meet Client Objectives
Performance driven, cost-effective, ethical,
unbiased and hassle-free clinical trial are some of the major demands that most clients come up with. CRN India is leaving no stone unturned when it comes to meeting clients objectives. The firm has partnered with qualified professionals to conduct all its clinical trial in compliance to ICH-GCP (Good Clinical Practice as defined by the International Conferences on Harmonization (ICH)) and New Drugs and Clinical Trials Rules, 2019 with necessary approval from Ethics committee/Institutional review board (EC/IRB).
“At CRN India, we offer services in two segments, firstly as an end to end trial management service for sponsors with the choice to opt for standalone services or package of services. This includes Study feasibilities, Investigator selection, Regulatory submissions, Study document translation and back translations, Site management to ensure GCP compliance, Coordination for data management and study completion procedures and Providing knowledgeable and trained staff for sites. Secondly, we offer Clinical Trial Execution which involves Randomization/Blinding/Languages Translation Services, Clinical Biostatistics, Clinical Data Management, Phase I/IIa and Early Clinical Trials, Phase II/III Clinical Trials, Clinical Monitoring and Late Phase Clinical Trials/Post Marketing Studies. We strive to deliver quality results within time, and answer any queries of the client, during as well after the trial has been conducted”, briefs Dr. Anit Singh.
Thriving On Success
Backed by its team of researchers and experts from various sphere of biochemical, immunological and medical fields, CRN India is successfully bridging the gaps in the Clinical Trial Domain. Today, the firm is also offering in-house training and certification program for our employees that includes GCP Training & Certification, Clinical Research Coordinator Certification, and Clinical Research Associate Certification. “At CRN India, we ensure that our employees are highly qualified professionals that have received the necessary training and certification and are up to date with the scientific and technologic advance around the globe. Together, we offer multitude of services offered by trained individuals, all under one roof, right from investigator selection, to protocol development (background research, writing study protocols and reports, data analysis and more) and most importantly a fast, secure ethical conduct of the study ensuring sanctity of the clients’ intellectual property”, speaks Dr. Anit.
We provide end-to-end trial management services for sponsors to meet their requirements for phase i-iv studies with the option to choose standalone services or package of services
Established in 2015, Clinical Research Network India has come a long way since inception. “I realized the need for a consortium of experienced clinicians, expert researchers and clinical research sites, all in one place, to aid investigators in conducting high level research and accelerate development of medical products/devices. Since its initiation, CRN India has been successfully conducting multiple clinical trials (Phase I – IV clinical trials) on various drugs, biologicals, vaccines, for different sponsors and has also been involved in promoting the same in the market. Currently, CRN India is involved in conducting various phases of vaccine trials against SARSCoV- 2 at multiple centres within India. CRN India is proud to be contributing its expertise in India’s fight against COVID-19”, Dr. Anit shares proudly.
Moving on, for the years to come, CRN India aspires to become the largest clinical research network in the India that would be committed to serve national and international pharma, biotech, medical device, diagnostic, foodnutraceutical, cosmetic industries and more. The integrated resources of CRN India provide unique advantages for conducting clinical research in India. Our goal is to provide a comprehensive solution to conducting clinical research in India, from start to finish”, signs-off Dr. Anit Singh.
Dr. Anit Singh, MBBS, MD (Aiims), CEO, CRN India
The extensive clinical trial experience Dr. Anit has garnered from his tenure at world's foremost pharamaceutical companies packed up with his MBBS & MD (AIIMS) degrees, enables him to expertly cater to his client’s requirements. His passion to innovate and commitment to serve the society coupled with his entrepreneurial spirit facilitate him to steer CRN India to newer heights. So far, he has participated in 200 clinical trials worldwide and has over 50 publications and abstracts to his credit.
He is also working as Medical Advisor to Multi Vaccines Development Program (MVDP) developed by the collaborative efforts of Department of Biotechnology, Ministry of Science and Technology, Government of India, and International Centre for Genetic Engineering and Biotechnology, New Delhi which is a unique intergovernmental organisation established as a special project of United Nations Industrial Development Organization (UNIDO) with mission to advance and accelerate cost effective development of vaccines against infectious diseases.
We use cookies to ensure you get the best experience on our website. Read more...
